SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Trevi Therapeutics, Inc. (TRVI) News

Follow Trevi Therapeutics, Inc. (TRVI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol TRVI Asset equity Sector Markets 90 days 8 Last 13.36 Updated Nov 09, 2026, 09:35 PM UTC Open live news feed Open TRVI chart & news
M Trevi Therapeutics Q3 Net Loss Widens on Higher R&D Costs EQUITY | Nov 09, 2026, 09:35 PM UTC M Trevi Therapeutics to Report Third-Quarter Financial Results EQUITY | Nov 02, 2026, 09:12 PM UTC H Trevi Therapeutics Q2 2026 Earnings Call Transcript Trevi Therapeutics (NASDAQ: TRVI ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire LIVE | Oct 12, 2026, 09:32 AM UTC L Harvest ETFs announces September 2026 Distributions Harvest Portfolios Group Inc. (“Harvest”) announces the following monthly distributions for Harvest ETFs in the following table for the month ending September 30, 2026. The distributions will be paid on or about October NEWS | Sep 23, 2026, 11:30 AM UTC L Trevi Therapeutics to participate in upcoming September conferences Trevi Therapeutics says it will participate in upcoming September conferences, highlighting its investigational therapy Haduvio for chronic cough in patients with idiopathic pulmonary fibrosis and non-IPF. EQUITY | Sep 03, 2026, 11:38 AM UTC L TRVI - Trevi Therapeutics to Participate in Upcoming September Conferences TRVI - Trevi Therapeutics to Participate in Upcoming September Conferences EQUITY | Sep 03, 2026, 11:30 AM UTC L Trevi Therapeutics to present at ERS Congress 2026 Trevi Therapeutics announced upcoming presentations at the European Respiratory Society (ERS) Congress 2026, per TradingView News. GEOPOLITICS | Aug 26, 2026, 11:37 AM UTC H TRVI - Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026 TRVI - Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026 GEOPOLITICS | Aug 26, 2026, 11:30 AM UTC L TRVI - Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 - Click For Relea TRVI - Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 EARNINGS | Jul 30, 2026, 08:05 PM UTC L TRVI - Trevi Therapeutics to Participate in Upcoming August Conferences TRVI - Trevi Therapeutics to Participate in Upcoming August Conferences EQUITY | Jul 28, 2026, 11:30 AM UTC L TRVI new Outperform W/ $36 PT @ BMO TRVI new Outperform W/ $36 PT @ BMO EQUITY | Jul 21, 2026, 11:15 AM UTC L TRVI lows -11% TRVI lows -11% EQUITY | Jul 20, 2026, 07:42 PM UTC L TRVI View GSK's decision to halt camlipixant in RCC as a positive for TRVI, ending the P2X3 class and leaving Haduvio the leading differenti TRVI View GSK's decision to halt camlipixant in RCC as a positive for TRVI, ending the P2X3 class and leaving Haduvio the leading differentiated candidate; Briley reiterate Buy and raise PT to $31 from $21 @ Briley EQUITY | Jul 20, 2026, 01:09 PM UTC H ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday U.S. stocks were lower, with the Nasdaq Composite falling around 400 points on Friday. Shares of ManpowerGroup Inc (NYSE: MAN ) rose sharply after the company reported upbeat second-quarter results and issued third-quart EARNINGS | Jul 17, 2026, 02:09 PM UTC L TRVI highs up around 12%, benefiting from GSK stopping its Chronic cough study TRVI highs up around 12%, benefiting from GSK stopping its Chronic cough study EQUITY | Jul 17, 2026, 02:08 PM UTC